Unravelling the adiponectin paradox: novel roles of adiponectin in the regulation of cardiovascular disease
British Journal of Pharmacology2016Vol. 174(22), pp. 4007–4020
Citations Over TimeTop 10% of 2016 papers
Abstract
This article is part of a themed section on Targeting Inflammation to Reduce Cardiovascular Disease Risk. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.22/issuetoc and http://onlinelibrary.wiley.com/doi/10.1111/bcp.v82.4/issuetoc.
Related Papers
- → Adiponectin in health and disease(2006)286 cited
- → Circulating anti-inflammatory adipokines High Molecular Weight Adiponectin and Zinc-α2-glycoprotein (ZAG) are inhibited in early sepsis, but increase with clinical recovery: a pilot study(2014)33 cited
- → Are leptin and adiponectin involved in recurrent pregnancy loss?(2018)16 cited
- [Adipocytokines and assay method in metabolic syndrome].(2010)
- → Characteristics of Adiponectin and Coronary Plaque – An Intravascular Ultrasound Study(2008)